140 related articles for article (PubMed ID: 36184258)
1. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
[TBL] [Abstract][Full Text] [Related]
2. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
4. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
[TBL] [Abstract][Full Text] [Related]
5. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
Messineo L; Carter SG; Taranto-Montemurro L; Chiang A; Vakulin A; Adams RJ; Carberry JC; Eckert DJ
Respirology; 2021 Sep; 26(9):878-886. PubMed ID: 34164887
[TBL] [Abstract][Full Text] [Related]
6. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
7. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
9. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
10. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
11. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
Messineo L; Norman D; Ojile J
J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
[TBL] [Abstract][Full Text] [Related]
12. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
14. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
16. Effect of oxybutynin and reboxetine on obstructive sleep apnea: a randomized, placebo-controlled, double-blind, crossover trial.
Berger M; Solelhac G; Marchi NA; Dussez R; Bradley B; Lecciso G; Heiniger G; Bayon V; Van Den Broecke S; Haba-Rubio J; Siclari F; Heinzer R
Sleep; 2023 Jul; 46(7):. PubMed ID: 36861433
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy for obstructive sleep apnoea in adults.
Smith I; Lasserson TJ; Wright J
Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
[TBL] [Abstract][Full Text] [Related]
18. Stepwise Add-On and Endotype-informed Targeted Combination Therapy to Treat Obstructive Sleep Apnea: A Proof-of-Concept Study.
Aishah A; Tong BKY; Osman AM; Pitcher G; Donegan M; Kwan BCH; Brown E; Altree TJ; Adams R; Mukherjee S; Eckert DJ
Ann Am Thorac Soc; 2023 Sep; 20(9):1316-1325. PubMed ID: 37159953
[No Abstract] [Full Text] [Related]
19. Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial.
Sands SA; Collet J; Gell LK; Calianese N; Hess LB; Vena D; Azarbarzin A; Bertisch SM; Landry S; Thomson L; Joosten SA; Hamilton GS; Edwards BA
Thorax; 2024 Feb; 79(3):259-268. PubMed ID: 38286618
[TBL] [Abstract][Full Text] [Related]
20. Randomised, controlled crossover trial of intermittent and continuous transcutaneous electrical stimulation of the genioglossus muscle for obstructive sleep apnoea.
Wu X; Zhao D; Hu W; Zheng Z; Zha S; Zhang Q; Hu K
Thorax; 2023 Jul; 78(7):713-720. PubMed ID: 36690924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
